Trial Profile

Adherence of a 1.600 mg single tablet 5-ASA treatment of Ulcerative colitis (EASI-trial)

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 28 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mesalazine (Primary)
Indications Ulcerative colitis
Focus Therapeutic Use
Acronyms EASI

Most Recent Events

25 Sep 2023 Planned End Date changed from 1 May 2023 to 1 Mar 2025.
25 Sep 2023 Planned primary completion date changed from 1 Sep 2022 to 31 Dec 2024.
03 Feb 2020 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com